NRX Pharmaceuticals Balance Sheet (2017-2026) | NRXP

Balance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
13.39M38.88M27.61M40.20M24.55M18.25M20.05M16.51M14.97M8.90M4.59M1.32M1.90M1.60M1.44M5.50M2.90M7.18M7.80M6.70M
Cash & Current Investments (Quarter)
13.39M38.88M27.61M40.20M24.55M18.25M20.05M16.51M14.97M8.90M4.59M1.32M1.90M1.60M1.44M5.50M2.90M7.18M7.80M6.70M
Receivables - Net (Quarter)
0.27M0.01M0.01M0.01M0.01M0.01M0.24M0.16M0.36M
Receivables - Other (Quarter)
0.01M0.01M0.01M3.09M
Receivables (Quarter)
0.27M0.01M0.01M0.01M0.01M0.01M3.33M0.16M0.36M
Prepaid Assets (Quarter)
0.05M6.35M5.11M2.07M6.52M4.85M0.33M3.25M2.02M4.19M1.08M0.13M0.65M0.42M0.21M1.71M1.68M0.34M0.29M0.47M
Current Assets (Quarter)
18.53M45.23M32.71M43.58M32.41M24.80M25.80M21.76M19.79M13.09M6.88M3.35M4.88M4.11M3.30M7.26M4.59M11.95M8.89M7.36M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.01M0.07M0.06M0.26M
Long-Term Investments (Quarter)
0.40M0.40M
Goodwill (Quarter)
0.61M1.79M1.79M
Intangibles (Quarter)
1.78M0.93M0.88M
Goodwill & Intangibles (Quarter)
2.39M2.72M2.67M
Other Non-Current Assets (Quarter)
0.01M0.02M0.01M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.43M0.44M0.38M0.36M0.34M0.33M0.25M0.24M0.25M0.28M
Non-Current Assets (Quarter)
0.01M0.02M0.01M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.43M0.44M0.38M0.36M0.35M0.33M0.25M3.05M4.06M4.54M
Assets (Quarter)
18.55M45.25M32.73M43.60M32.43M24.82M25.82M21.78M19.81M13.11M7.32M3.79M5.26M4.46M3.65M7.59M4.84M15.00M12.96M11.90M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
6.27M5.56M3.69M4.31M3.08M2.17M2.08M3.78M2.21M3.63M4.63M6.26M5.01M4.87M4.13M4.31M3.63M4.26M4.27M4.40M
Notes Payables (Quarter)
22.85M1.26M0.29M0.50M0.02M0.06M0.04M12.19M0.04M10.07M0.02M0.03M1.90M5.64M9.85M9.85M9.91M12.30M8.77M
Payables (Quarter)
29.11M6.82M3.98M4.81M3.10M2.22M2.11M15.96M2.24M13.70M4.65M6.29M5.01M6.77M9.77M14.16M13.48M14.17M16.57M13.16M
Accumulated Expenses (Quarter)
1.51M2.00M0.46M0.02M0.29M5.07M0.92M5.05M5.78M4.73M0.83M5.30M9.59M9.44M10.15M9.84M0.44M0.42M11.34M0.39M
Other Accumulated Expenses (Quarter)
0.83M0.63M1.05M0.76M0.30M1.62M0.97M1.15M1.18M0.74M0.08M0.99M0.21M0.24M0.47M0.20M0.05M0.10M0.00M0.07M
Short term Debt (Quarter)
25.87M26.28M4.58M2.48M0.94M0.63M0.32M0.38M0.15M
Current Leases (Quarter)
0.09M0.21M0.11M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
22.85M1.26M0.29M0.14M0.02M0.06M
Total Current Liabilities (Quarter)
57.80M36.77M11.92M15.59M22.06M22.62M19.33M19.05M20.30M21.86M32.75M40.45M40.59M28.58M25.18M
Non-Current Liabilities
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
7.65M2.98M5.01M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
0.14M0.20M0.93M
Other Non-Current Liabilities (Quarter)
-1.10M-1.10M-1.10M0.02M0.01M1.90M5.64M9.85M16.27M15.86M12.30M8.77M
Total Non-Current Liabilities (Quarter)
59.41M37.87M13.02M19.03M23.65M21.38M21.23M22.90M24.19M24.89M16.59M16.95M
Total Liabilities (Quarter)
58.31M36.77M11.92M11.91M7.08M8.04M18.41M22.06M22.62M19.33M19.05M18.86M23.66M23.28M26.87M32.75M40.45M40.75M28.89M25.72M
Shareholder's Equity
Total Debt (Quarter)
25.87M26.28M4.58M2.48M0.94M0.63M0.32M0.38M0.15M
Common Equity (Quarter)
-39.77M8.48M20.81M31.69M25.35M16.78M7.41M-0.28M-2.81M-6.22M-11.73M-15.07M-18.39M-18.82M-23.22M-25.16M-35.62M-25.75M-15.94M-13.80M
Liabilities and Shareholders Equity (Quarter)
18.55M45.25M32.73M43.60M32.43M24.82M25.82M21.78M19.81M13.11M7.32M3.79M5.26M4.46M3.65M7.59M4.84M15.00M12.96M11.90M
Retained Earnings (Quarter)
-115.79M161.26M203.99M228.31M228.96M-212.76M230.34M0.11M-0.02M-0.02M-253.15M-0.00M-267.57M-269.19M-278.27M258.61M-301.37M-307.26M-306.89M294.48M
Preferred Shares (Quarter)
0.00M
Treasury Shares (Quarter)
1.00M1.00M1.00M1.00M0.67M0.12M0.07M0.07M0.03M0.03M0.03M